实用医学杂志
實用醫學雜誌
실용의학잡지
THE JOURNAL OF PRACTICAL MEDICINE
2014年
14期
2204-2207
,共4页
万君%叶菊风%叶俊%郭进强
萬君%葉菊風%葉俊%郭進彊
만군%협국풍%협준%곽진강
穿心莲内酯%四氯化碳%肝损伤
穿心蓮內酯%四氯化碳%肝損傷
천심련내지%사록화탄%간손상
Andrographolide%Carbon tetrachloride%Liver injury
目的:研究穿心莲内酯(AP)对小鼠急性四氯化碳(CCl4)肝损伤的保护作用及其机制。方法:40只小鼠随机分成5组,正常对照组、肝损伤模型组、AP低剂量组(50 mg/kg)、高剂量组(100 mg/kg)和阳性药物组。分别测定小鼠血清中丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)含量;肝匀浆中丙二醛(MDA)、还原型谷胱甘肽(GSH)的含量及肝组织病理学变化;逆转录PCR(RT-PCR)检测小鼠肝脏中肿瘤坏死因子α(TNF-α)、血红素加氧酶-1(HO-1)mRNA水平。结果:AP高剂量组(100 mg/kg)降低小鼠血清中ALT、AST水平,提高肝组织中GSH活性,降低MDA水平,差异均有统计学意义(P<0.05);病理镜检显示AP高剂量组明显减轻肝损伤;RT-PCR结果显示,AP高剂量组TNF-α表达水平降低,而HO-1表达增强,差异均有统计学意义(P<0.05)。结论:AP通过抑制脂质过氧化反应,降低组织中氧自由基的生成保护急性四氯化碳肝损伤,其机制可能与抑制TNF-α的表达,诱导HO-1表达有关。
目的:研究穿心蓮內酯(AP)對小鼠急性四氯化碳(CCl4)肝損傷的保護作用及其機製。方法:40隻小鼠隨機分成5組,正常對照組、肝損傷模型組、AP低劑量組(50 mg/kg)、高劑量組(100 mg/kg)和暘性藥物組。分彆測定小鼠血清中丙氨痠氨基轉移酶(ALT)、天門鼕氨痠氨基轉移酶(AST)含量;肝勻漿中丙二醛(MDA)、還原型穀胱甘肽(GSH)的含量及肝組織病理學變化;逆轉錄PCR(RT-PCR)檢測小鼠肝髒中腫瘤壞死因子α(TNF-α)、血紅素加氧酶-1(HO-1)mRNA水平。結果:AP高劑量組(100 mg/kg)降低小鼠血清中ALT、AST水平,提高肝組織中GSH活性,降低MDA水平,差異均有統計學意義(P<0.05);病理鏡檢顯示AP高劑量組明顯減輕肝損傷;RT-PCR結果顯示,AP高劑量組TNF-α錶達水平降低,而HO-1錶達增彊,差異均有統計學意義(P<0.05)。結論:AP通過抑製脂質過氧化反應,降低組織中氧自由基的生成保護急性四氯化碳肝損傷,其機製可能與抑製TNF-α的錶達,誘導HO-1錶達有關。
목적:연구천심련내지(AP)대소서급성사록화탄(CCl4)간손상적보호작용급기궤제。방법:40지소서수궤분성5조,정상대조조、간손상모형조、AP저제량조(50 mg/kg)、고제량조(100 mg/kg)화양성약물조。분별측정소서혈청중병안산안기전이매(ALT)、천문동안산안기전이매(AST)함량;간균장중병이철(MDA)、환원형곡광감태(GSH)적함량급간조직병이학변화;역전록PCR(RT-PCR)검측소서간장중종류배사인자α(TNF-α)、혈홍소가양매-1(HO-1)mRNA수평。결과:AP고제량조(100 mg/kg)강저소서혈청중ALT、AST수평,제고간조직중GSH활성,강저MDA수평,차이균유통계학의의(P<0.05);병리경검현시AP고제량조명현감경간손상;RT-PCR결과현시,AP고제량조TNF-α표체수평강저,이HO-1표체증강,차이균유통계학의의(P<0.05)。결론:AP통과억제지질과양화반응,강저조직중양자유기적생성보호급성사록화탄간손상,기궤제가능여억제TNF-α적표체,유도HO-1표체유관。
Objective To investigate the role of andrographolide (AP) in protection of carbon tetrachloride (CCl4)-induced acute liver injury in mice and the possible mechanisms. Methods The mice were randomly divided into five groups, including two groups with different doses of AP (50 mg/kg and100 mg/kg), a control group, a CCl4 model group, and a silymarin group. Serum levels of alanine aminotransferase (ALT), aspartateminotransferase (AST), hepatic malondialdehyde (MDA), and glutathione (GSH) were examined. Pathological changes in the liver were observed. RT-PCR was used to detect the expressions of tumor necrosis factor-a (TNF-α) and heme oxygenase-1 (HO-1) mRNA. Results As compared with CCl4 model group, serum levels of ALT and AST and hepatic MDA activity were significantly decreased in AP group (100 mg·kg-1), along with a remarkable increase in hepatic GSH content. Pretreatment with AP at a high dose alleviated histopathological changes induced by CCl4. A markedly increased level of TNF-a induced by CCl4 was reduced by AP, while HO-1at transcriptional level was dramatically elevated following AP pretreatment. Conclusions AP plays a role in protection of CCl4-induced acute liver injury by inhibiting lipid peroxidation and reducing formation of free radicals, the mechanism may be involved in inhibition of TNF-αand activation of HO-1.